Literature DB >> 1671222

Structural and functional analysis of the mouse mdr1b gene promoter.

D Cohen1, R L Piekarz, S I Hsu, R A DePinho, N Carrasco, S B Horwitz.   

Abstract

The overproduction of P-glycoprotein, an integral membrane protein thought to function as a drug efflux pump, is the hallmark of the multidrug resistance phenotype. In murine multidrug resistant J774.2 cell lines, distinct mdr genes, mdr1a and mdr1b, encode unique P-glycoprotein isoforms. To examine the transcriptional regulation of the mdr1b gene, its promoter was isolated and characterized. The transcription initiation site was mapped by primer extension, and the 5'-flanking region was sequenced. Several potential regulatory elements were identified in this region. A transient expression vector was constructed by fusion of 540 base pairs of 5'-flanking sequence and part of the first untranslated exon to the chloramphenicol acetyltransferase (CAT) gene. When transfected into monkey kidney COS-1, rat pituitary GH3 or T47D human breast cells, the mdr1b 5'-flanking sequences were capable of driving CAT expression. Transient transfection studies using deletion subclones of the mdr1b-CAT construct were done to locate potential cis-acting sequences. The studies indicate the presence of cis-acting elements in the 5'-flanking region of the mdr1b gene. The implications of these findings for expression and regulation of the mdr1b gene are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor.

Authors:  T W Gant; J A Silverman; S S Thorgeirsson
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

Review 2.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

3.  De novo generation of simple sequence during gene amplification.

Authors:  L S Kirschner
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

4.  Cloning and regulation of the rat mdr2 gene.

Authors:  P C Brown; S S Thorgeirsson; J A Silverman
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

5.  High-resolution genetic map and YAC contig around the mouse neurological locus reeler.

Authors:  J C Montgomery; M H Guarnieri; K E Tartaglia; L A Flaherty
Journal:  Mamm Genome       Date:  1994-12       Impact factor: 2.957

6.  Functional analysis of the human somatic angiotensin I-converting enzyme gene promoter.

Authors:  P Testut; F Soubrier; P Corvol; C Hubert
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

7.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

8.  Activation of the mouse mdr3 gene by insertion of retroviruses in multidrug-resistant P388 tumor cells.

Authors:  P Lepage; A Devault; P Gros
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

9.  Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain.

Authors:  Grazia Tripodi; Lorena Citterio; Tatiana Kouznetsova; Chiara Lanzani; Monica Florio; Rossana Modica; Elisabetta Messaggio; John M Hamlyn; Laura Zagato; Giuseppe Bianchi; Jan A Staessen; Paolo Manunta
Journal:  Am J Hypertens       Date:  2009-02-05       Impact factor: 2.689

10.  Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.

Authors:  Christoph K Thoeringer; Thomas Wultsch; Anaid Shahbazian; Evelin Painsipp; Peter Holzer
Journal:  Psychoneuroendocrinology       Date:  2007-09-19       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.